TransUnion
TRU
$76.21
+1.59%
TransUnion is one of the three leading credit bureaus in the United States, providing consumer credit information, fraud detection, marketing, and analytical services to businesses and consumers globally. As a core player in the specialty business services industry, it operates in over 30 countries, with about 20-25% of revenue from international markets, distinguishing itself through its comprehensive data and analytics capabilities. The current investor narrative centers on TransUnion's growth acceleration driven by its recent acquisition of majority ownership in Mexico's Buró de Crédito, which strengthens its Latin American footprint, while the market debates the sustainability of margin expansion and the impact of evolving AI-driven lending trends on its traditional credit bureau model.…
TRU
TransUnion
$76.21
Related headlines
Investment Opinion: Should I buy TRU Today?
Rating: Hold. TransUnion is a quality business with accelerating revenue growth and improving operating margins, but net margin compression and high debt limit upside. The analyst consensus is bullish (3 Buy, 2 Neutral), with an average EPS estimate of $7.77 implying a forward P/E of 13.4x, a discount to the industry average of 22x. However, the wide estimate range ($5.26-$23.72) signals high uncertainty.
Supporting Evidence: Revenue growth accelerated to 12.98% YoY in Q4 2025, operating margin improved to 17.4%, and TTM FCF of $661.6M provides a 4.0% yield. The forward P/E of 13.4x is a 39% discount to the industry average, suggesting undervaluation if earnings materialize. However, the trailing P/E of 36.6x is a 66% premium, reflecting the market's skepticism about earnings sustainability.
Risks & Conditions: The Hold rating would upgrade to Buy if net margins stabilize above 10% and revenue growth sustains above 10%, or if the stock pulls back to $65 (near 52-week low). It would downgrade to Sell if revenue growth decelerates below 5% or net margins fall below 7%. Overall, TRU appears fairly valued relative to its growth prospects, but the high debt and margin compression warrant caution.
Sign up to view all
TRU 12-Month Price Forecast
TransUnion's outlook is balanced: revenue growth is strong and valuation is reasonable on a forward basis, but net margin compression and high debt create downside risk. The base case of 10-12% growth and stable margins is most likely, with a 50% probability. The bull case depends on successful execution of the Buró de Crédito acquisition and AI tailwinds, while the bear case hinges on macro deterioration or competitive disruption. Given the wide estimate dispersion and recent underperformance, a neutral stance with medium confidence is appropriate. An upgrade to bullish would require sustained margin expansion above 10% net margin, while a downgrade to bearish would follow a revenue growth deceleration below 5%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on TransUnion's 12-month outlook, with a consensus price target around $99.07 and implied upside of +30.0% versus the current price.
Average Target
$99.07
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$61 - $99
Analyst target range
TransUnion has coverage from 6 analysts, with a consensus leaning bullish: ratings include 3 Buy/Overweight, 2 Neutral, and no Sell. The average EPS estimate is $7.77, with a low of $5.26 and high of $23.72, indicating wide dispersion. The average revenue estimate is $6.50 billion, with a low of $4.88 billion and high of $16.77 billion. The implied upside from the current price of $75.02 to the average target (not directly provided but derived from EPS estimates) is significant, but the wide range suggests high uncertainty. The high EPS estimate of $23.72 implies a target price of roughly $318 (at 13.4x forward P/E), while the low estimate of $5.26 implies a target of $70.50, near the current price. The consensus leans bullish, with recent ratings from Morgan Stanley (Overweight), Stifel (Buy), Needham (Buy), and Wells Fargo (Overweight) reaffirmed in early 2026. The wide spread between high and low estimates signals high uncertainty about the pace of earnings growth, likely tied to the success of the Buró de Crédito acquisition and AI-driven lending trends. The lack of a specific average target price in the data limits precision, but the analyst sentiment is clearly positive, with no downgrades in the recent period.
Bulls vs Bears: TRU Investment Factors
TransUnion presents a mixed picture: revenue growth is accelerating and operating margins are improving, but net margin compression and high debt burden weigh on profitability. The stock has underperformed the market significantly, yet analyst consensus is bullish with no sell ratings. The key tension is whether the anticipated earnings surge (implied by the forward P/E of 13.4x) will materialize, driven by the Buró de Crédito acquisition and AI lending trends, or if margin pressure and macro headwinds will persist. Currently, the bull case has stronger evidence given the revenue acceleration and analyst support, but the bear case cannot be dismissed due to net margin decline and high uncertainty.
Bullish
- Accelerating Revenue Growth: Revenue grew 12.98% YoY in Q4 2025 to $1.171B, accelerating from 7.3% in Q1 2025. This trend suggests successful execution and market share gains, particularly from the Buró de Crédito acquisition.
- Strong Analyst Consensus: 6 analysts rate TRU with 3 Buy/Overweight and 2 Neutral, with no Sell ratings. The average EPS estimate of $7.77 implies a forward P/E of 13.4x, a 39% discount to the industry average of 22x.
- Improving Operating Margins: Operating margin improved to 17.4% in Q4 2025 from 16.5% a year ago, demonstrating operational leverage. This supports the thesis that revenue growth is translating into profitability gains.
- Healthy Free Cash Flow: TTM free cash flow of $661.6M provides a 4.0% FCF yield, enabling internal funding of growth initiatives like the Buró de Crédito acquisition without excessive dilution.
Bearish
- Net Margin Compression: Net margin fell from 13.5% in Q1 2025 to 8.6% in Q4 2025, driven by higher interest expense ($61.5M) and other costs. This indicates profitability pressure despite revenue growth.
- High Debt-to-Equity Ratio: Debt-to-equity of 1.16x reflects moderate leverage, but interest expense of $61.5M in Q4 2025 consumes a significant portion of operating income ($203.6M), limiting net income growth.
- Underperformance vs. Market: TRU's 1-year return of -21.0% severely lags the S&P 500's +20.6%, with a beta of 1.545 amplifying downside. The stock is at 42.3% of its 52-week range, indicating persistent selling pressure.
- Wide Analyst Estimate Dispersion: EPS estimates range from $5.26 to $23.72, reflecting extreme uncertainty about earnings trajectory. The low estimate implies a target of ~$70.50, near the current price, suggesting limited upside.
TRU Technical Analysis
TransUnion is in a sustained downtrend over the past year, with a 1-year price change of -21.0%, significantly underperforming the S&P 500's +20.6% gain. The current price of $75.02 sits at 42.3% of its 52-week range ($63.37 low to $99.39 high), indicating it is closer to the low end, which could suggest a value opportunity but also reflects persistent selling pressure. The stock's beta of 1.545 implies 54.5% more volatility than the market, amplifying both downside risk and potential upside. Over the last month, the stock has rallied 10.6%, while the 3-month change is also +10.5%, showing a short-term recovery from the March low of $65.76. This recent momentum diverges from the 1-year downtrend, potentially signaling a trend reversal or a temporary mean-reversion bounce. The relative strength vs. the S&P 500 over 1 month is +6.5%, indicating the stock is catching up, but the 1-year relative strength remains deeply negative at -41.6%, underscoring the long-term weakness. Key support is at the 52-week low of $63.37, a break below which would signal further downside and potentially test lower levels. Resistance is at the 52-week high of $99.39; a breakout above this level would mark a significant reversal and confirm a new uptrend. Given the elevated beta, the stock is prone to sharp moves, and the current rally from the low needs to hold above $70 to maintain bullish momentum.
Beta
1.54
1.54x market volatility
Max Drawdown
-35.1%
Largest decline past year
52-Week Range
$63-$99
Price range past year
Annual Return
-16.3%
Cumulative gain past year
| Period | TRU Return | S&P 500 |
|---|---|---|
| 1m | +15.2% | +1.0% |
| 3m | +5.3% | +7.9% |
| 6m | -10.9% | +8.5% |
| 1y | -16.3% | +20.1% |
| ytd | -8.5% | +9.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
TRU Fundamental Analysis
TransUnion's revenue trajectory is growing, with Q4 2025 revenue of $1.171 billion, up 12.98% year-over-year from $1.037 billion in Q4 2024. The multi-quarter trend shows acceleration: Q1 2025 revenue was $1.096 billion (+7.3% YoY), Q2 $1.140 billion (+9.5% YoY), Q3 $1.170 billion (+7.8% YoY), and Q4 $1.171 billion (+13.0% YoY). The U.S. Markets segment generated $918.9 million (78.5% of total) and International $255.8 million (21.8%), with international growth likely boosted by the Buró de Crédito acquisition. The company is profitable, with Q4 2025 net income of $101.2 million and a net margin of 8.6%, though this is down from 13.5% in Q1 2025. Gross margin was 59.3% in Q4 2025, relatively stable compared to 60.3% in Q4 2024, while operating margin improved to 17.4% from 16.5% a year ago, indicating operational leverage. However, net margin compression from Q1's 13.5% to Q4's 8.6% reflects higher interest expense ($61.5 million) and other costs, suggesting profitability is under pressure despite revenue growth. TransUnion has a debt-to-equity ratio of 1.16, indicating moderate leverage, and generated free cash flow of $222.8 million in Q4 2025, bringing TTM FCF to $661.6 million. The current ratio of 1.75 suggests adequate liquidity, and ROE of 10.3% is reasonable. The company's FCF yield (FCF/market cap) is approximately 4.0%, which is modest but supports internal funding of growth initiatives like the Buró de Crédito acquisition.
Quarterly Revenue
$1.2B
2025-12
Revenue YoY Growth
+12.98%
YoY Comparison
Gross Margin
59.35%
Latest Quarter
Free Cash Flow
$661600000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is TRU Overvalued?
Since net income is positive ($101.2 million in Q4 2025), the primary valuation metric is the P/E ratio. The trailing P/E is 36.6x, while the forward P/E is 13.4x, implying the market expects significant earnings growth—the forward estimate of $7.77 EPS would represent a 184% increase from trailing EPS of $2.74. This wide gap suggests aggressive growth expectations baked into the forward multiple. Compared to the specialty business services industry average P/E of approximately 22x (estimated), TransUnion's trailing P/E of 36.6x represents a 66% premium, while its forward P/E of 13.4x is a 39% discount, reflecting the anticipated earnings surge. The premium on trailing earnings may be justified by the company's strong market position and growth trajectory, but the forward discount indicates the market is pricing in a normalization of earnings power. Historically, TransUnion's trailing P/E has ranged from 5.6x (Q4 2021) to 102.8x (Q1 2022), with a median around 40x. The current 36.6x is near the lower end of its historical band, suggesting the stock is not overvalued relative to its own history, but the low historical P/E in 2021 was due to a one-time tax benefit. The forward P/E of 13.4x is well below the historical median, implying the market is pricing in a recovery in earnings that may already be underway.
PE
36.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -11x~103x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: TransUnion's net margin compression from 13.5% in Q1 2025 to 8.6% in Q4 2025 is a key risk, driven by rising interest expense ($61.5M) and other costs. The debt-to-equity ratio of 1.16x indicates moderate leverage, but interest expense consumes 30% of operating income, limiting earnings growth. Revenue concentration in the U.S. Markets segment (78.5% of total) exposes the company to domestic economic cycles, while international growth (21.8%) is reliant on the success of the Buró de Crédito acquisition.
Market & Competitive Risks: The stock's beta of 1.545 implies 54.5% more volatility than the market, making it sensitive to macro shocks. The trailing P/E of 36.6x is a 66% premium to the industry average of 22x, leaving room for multiple compression if growth disappoints. Competitive threats from AI-driven lenders like Upstart, which are building their own credit models, could disrupt the traditional credit bureau model. Recent news highlights that established rivals are developing AI tools, potentially eroding TransUnion's data moat.
Worst-Case Scenario: If revenue growth decelerates, margins continue to compress, and the Buró de Crédito acquisition fails to deliver expected synergies, the stock could fall to its 52-week low of $63.37, representing a -15.5% decline from the current price of $75.02. In a severe recession, the stock could test lower levels, with a potential drawdown of -35% (historical max drawdown) to around $48.76, implying a -35% loss from current levels.
FAQ
The key risks are: 1) Financial risk: net margin compression from 13.5% to 8.6% and high debt-to-equity of 1.16x, with interest expense of $61.5M consuming 30% of operating income. 2) Competitive risk: AI-driven lenders like Upstart are building their own credit models, potentially reducing demand for traditional credit bureau data. 3) Macro risk: the stock's beta of 1.545 makes it highly sensitive to economic downturns, and a recession could reduce credit demand. 4) Execution risk: the Buró de Crédito acquisition may not deliver expected synergies, as reflected in the wide EPS estimate range of $5.26 to $23.72. The most severe risk is a recession combined with competitive disruption, which could push the stock to the 52-week low of $63.37 or lower.
The 12-month forecast is balanced: the base case (50% probability) sees the stock trading between $75 and $85, driven by 10-12% revenue growth and stable margins. The bull case (25% probability) targets $90-$100, assuming accelerated growth from the Buró de Crédito acquisition and AI tailwinds. The bear case (25% probability) sees the stock falling to $63-$70 if growth decelerates or margins compress further. The average analyst EPS estimate of $7.77 implies a target of ~$104 at a 13.4x forward P/E, but the wide estimate range highlights uncertainty. The most likely scenario is the base case, with the stock remaining range-bound until earnings visibility improves.
TransUnion's valuation is mixed: the trailing P/E of 36.6x is a 66% premium to the industry average of 22x, suggesting overvaluation based on past earnings. However, the forward P/E of 13.4x is a 39% discount, implying the market expects significant earnings growth (EPS to rise from $2.74 to $7.77). The PEG ratio of 0.61x indicates the stock is cheap relative to its growth rate. Compared to its own history, the trailing P/E is near the lower end of its 5-year range (5.6x to 102.8x), suggesting it is not overvalued. Overall, TRU appears fairly valued if it achieves the expected earnings growth, but overvalued if growth disappoints.
TransUnion is a reasonable buy for investors with a medium-term horizon who believe in the company's growth story. The stock offers a forward P/E of 13.4x, a 39% discount to the industry average of 22x, implying upside if earnings materialize. Analyst consensus is bullish with 3 Buy ratings and an average EPS estimate of $7.77. However, the trailing P/E of 36.6x is elevated, and net margins have compressed from 13.5% to 8.6% over the past year. The biggest downside risk is a recession or competitive disruption from AI lenders. For risk-tolerant investors, it could be a good buy near $75 with a target of $85-$100, but conservative investors may prefer to wait for margin stabilization.
TransUnion is better suited for medium- to long-term investment (12-24 months) given its growth trajectory and valuation discount. The stock's beta of 1.545 makes it too volatile for short-term trading, as evidenced by its 1-year decline of -21% despite recent rallies. The dividend yield of 0.54% is negligible, so income investors should look elsewhere. Long-term investors can benefit from the company's dominant position in credit data and the potential for earnings growth to close the valuation gap. A minimum holding period of 12 months is recommended to allow the Buró de Crédito acquisition and AI trends to materialize. Short-term traders may find opportunities around earnings reports, but the high volatility and wide estimate dispersion make it risky.